Pfizer, BioNTech: FDA full approval review hopefully by January
Pfizer Inc. and BioNTech SE stated on Friday they are hoping the United States Food and Drug Administration (FDA) will review their application for the full approval of their vaccine against COVID-19 ...
| Continue reading